F-Prime Capital
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Seed, Series A, Series B, Growth, Late Stage, Pre-IPO, Buyout, Turnaround, Distressed, Early Stage
Geographical Focus
United States, United Kingdom, Canada, Germany, Japan, Australia, Europe, Singapore, China, India, Brazil, France, Italy, United Arab Emirates, Spain, Mexico, South Korea, Saudi Arabia, Netherlands, South Africa, Russia, New Zealand, Sweden, Israel, Chile, Argentina, Colombia
Industries Focus
- Technology
- Healthcare
- Consumer Goods
- HealthTech
- FinTech
- E-commerce
- Artificial Intelligence
- Life Sciences
- Healthcare Services
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Medtech
- Crypto
- Machine Learning
- Biotechnology
- Regenerative Medicine
- Enterprise Software
- Consumer Health
- Genomics
- Immuno-Oncology
- Rare Diseases
- Frontier Tech
- Healthcare IT
- Health IT & Services
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 1946
F-Prime Capital is a prominent venture capital firm specializing in healthcare and biotechnology investments worldwide. As the venture capital arm of Fidelity Investments, F-Prime Capital leverages Fidelity's extensive resources and expertise to identify and support innovative companies in the healthcare sector. The firm focuses on a broad range of investment stages, from seed funding to late-stage growth, and is committed to building long-term value for its portfolio companies and co-investors.
F-Prime Capital's investment strategy encompasses a diverse array of sectors within the healthcare and biotechnology industries, including biotechnology, medical devices, healthcare IT, pharmaceuticals, diagnostics, and digital health. The firm has a global investment approach, with a geographical focus spanning North America, Europe, Asia, and select markets in Latin America, the Middle East, and Africa. This extensive reach enables F-Prime Capital to identify and invest in promising companies across various regions and stages of development.
With a strong track record of successful investments, F-Prime Capital has demonstrated a commitment to advancing healthcare innovation and improving patient outcomes. The firm's portfolio includes a wide range of companies, from early-stage startups to established enterprises, reflecting its dedication to fostering growth and innovation in the healthcare and biotechnology sectors.
Requirements
- Innovative healthcare and technology solutions
- Strong founding teams
- Scalable business models
- Global market potential
- Commitment to positive societal impact
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Denali Therapeutics
- Repare Therapeutics
- ThoughtSpot
- Capital Rx
- Inflammatix
- Sana Biotechnology
- Prime Medicine
- Recurly
- Bicara Therapeutics
- Cytek Biosciences
- Flywire
- Charm Therapeutics
- Peptone Ltd.
- Affinia Therapeutics
- Illumina
- ARTBIO
- Spinwheel
- Canary Technologies
- Ensoma
- Dispatch
Mentioned In
-
$19.95
-
$49.95
-
$9.95
-
$14.95
-
$19.95
-
$39.95
-
$19.95
-
$24.95
-
$19.95
-
$19.95
-
$24.95
-
$99.00
-
$299.00
Claim this Investor
Are you an official representative of F-Prime Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim